# EPZICOM
> **ANDA204004** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2016-01-15
## Drug
- **FDA Application Number:** ANDA204004
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPZICOM
- **Generic name:** Abacavir
- **Active ingredients:** ABACAVIR; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMS INC
- **First approval:** 2016-01-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204004)
---
*AI Analytics · CC0 1.0*